Bengaluru: The U.S. Department of Agriculture has given a conditional approval 
to Zoetis to use its bird flu vaccine in poultry, the animal healthcare company said on Friday.
A conditional approval, called a conditional license, is used for emergencies,
limited market availability, or other special circumstance and is issued for
a finite period of time.
Separately, Moderna is developing a bird flu vaccine for humans and has received
about $766 million from the U.S. government for its advancement.
The company said last month it was preparing to advance its experimental shot, mRNA-1018, into late-stage trials based on preliminary data from an early- to mid-stage study.
Complete Article
	
	
		
			
				
					
						 
					
				
			
			
				
					
						
							 pharma.economictimes.indiatimes.com
						
					
					pharma.economictimes.indiatimes.com
				
			
		
	
				
			to Zoetis to use its bird flu vaccine in poultry, the animal healthcare company said on Friday.
A conditional approval, called a conditional license, is used for emergencies,
limited market availability, or other special circumstance and is issued for
a finite period of time.
Separately, Moderna is developing a bird flu vaccine for humans and has received
about $766 million from the U.S. government for its advancement.
The company said last month it was preparing to advance its experimental shot, mRNA-1018, into late-stage trials based on preliminary data from an early- to mid-stage study.
Complete Article
 
					
				US gives conditional nod to Zoetis' bird flu vaccine for poultry
Zoetis Bird Flu Vaccine: Bird flu has infected nearly 70 people in the United States, with one death, since last April. Most of those infections have been among farm workers exposed to infected poultry or cows.
				 pharma.economictimes.indiatimes.com
						
					
					pharma.economictimes.indiatimes.com
				 
	 
 
		 
 
		 
 
		

 
 
		
 
 
		 
 
		